CC BY-NC-ND 4.0 · AJP Rep 2018; 08(04): e343-e348
DOI: 10.1055/s-0038-1676289
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Maternal and Fetal Outcomes in Pregnancies affected by Bone and Soft Tissue Tumors

Ernesto Antonio Figueiro-Filho
1   Division of Maternal-Fetal Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
,
Hythem Al-Sum
2   Division of Maternal-Fetal Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia
,
Jacqueline Parrish
1   Division of Maternal-Fetal Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
,
Jay S. Wunder
3   Musculoskeletal Oncology Unit, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
4   Division of Orthopaedic Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
,
Cynthia Maxwell
1   Division of Maternal-Fetal Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Funding None
Further Information

Publication History

20 September 2018

16 October 2018

Publication Date:
28 November 2018 (online)

Abstract

Objective This study was aimed to describe perinatal outcome of a cohort of pregnant patients with bone and soft tissue tumors and to compare the current series with our group's previously reported experience.

Methods Pregnant women diagnosed before and during pregnancy were identified, retrospectively, for the years 2004 to 2014. Relevant maternal and neonatal data were collected.

Results Forty-eight patients were identified. Ten cases were diagnosed during pregnancy. Pelvis, abdomen, and extremities were the most common tumor locations. Osteosarcoma, liposarcoma, and Ewing's sarcoma were the most common histological types and comprise more than 50% of the cases. Metastases occurred in nine cases. Most of the cases (60%) were treated surgically during pregnancy and delivery occurred at term. Chemotherapy was delayed until after delivery. There were no perinatal or infant deaths. Patients presented with advanced maternal disease in 18% in previous report (1983–2003) versus 40% in present report (2004–2014). Metastases were present in 40% and maternal death rate was approximately 20% in both cohorts.

Conclusion Pregnant women with bone and soft tissue tumors are candidates for standard surgical management during pregnancy. Other treatments, such as chemotherapy and radiotherapy must be evaluated for each woman on a case-by-case basis. Iatrogenic prematurity was common in our findings.

Précis

Pregnant women with sarcoma are candidates for surgical management during pregnancy. Chemotherapy and radiotherapy must be evaluated individually. Iatrogenic prematurity is a prominent risk.


 
  • References

  • 1 Peccatori FA, Azim Jr HA, Orecchia R. , et al; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi160-vi170
  • 2 Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002; 7 (04) 279-287
  • 3 Puvanesarajah V, Spiker AM, Shannon BA, Grundy M, Levin AS, Morris CD. Evaluation and management of the pregnant patient with suspected primary musculoskeletal tumor or metastatic carcinoma to bone. Surg Oncol 2016; 25 (03) 212-222
  • 4 Maxwell C, Barzilay B, Shah V, Wunder JS, Bell R, Farine D. Maternal and neonatal outcomes in pregnancies complicated by bone and soft-tissue tumors. Obstet Gynecol 2004; 104 (02) 344-348
  • 5 Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in pregnant women. Prognosis, therapeutic implications, and literature review. Cancer 1985; 56 (09) 2326-2331
  • 6 Simon MA, Phillips WA, Bonfiglio M. Pregnancy and aggressive or malignant primary bone tumors. Cancer 1984; 53 (11) 2564-2569
  • 7 Zarkavelis G, Petrakis D, Fotopoulos G, Mitrou S, Pavlidis N. Bone and soft tissue sarcomas during pregnancy: a narrative review of the literature. J Adv Res 2016; 7 (04) 581-587
  • 8 Corrêa RR, Espindula AP, Machado JR. , et al. Osteosarcoma in a pregnant woman: case report. Arch Gynecol Obstet 2012; 286 (06) 1601-1602
  • 9 Roessler PP, Schmitt J, Fuchs-Winkelmann S, Efe T. Chondrosarcoma of the tibial head during pregnancy: a challenging diagnosis. BMJ Case Rep 2014; 2014: 201
  • 10 Matsuda S, Tanaka K, Harimaya K, Matsumoto Y, Sato H, Iwamoto Y. Treatment of myxoid liposarcoma in pregnancy. Clin Orthop Relat Res 2000; ;( (376) 195-199
  • 11 Oh SE, Kim HJ, Choi SJ, Oh SY, Roh CR, Kim JH. A case of huge retroperitoneal liposarcoma in pregnancy. Obstet Gynecol Sci 2014; 57 (03) 236-239
  • 12 Huo D, Liu L, Tang Y. Giant retroperitoneal liposarcoma during pregnancy: a case report. World J Surg Oncol 2015; 13: 145
  • 13 Al-Bozom IA. Placental metastases from maternal rhabdomyosarcoma. Ann Saudi Med 2000; 20 (3, 4): 294-296
  • 14 Siepermann M, Koscielniak E, Dantonello T. , et al. Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer 2012; 58 (01) 104-106
  • 15 Taghavi K, Sykes P, Innes C. , et al. Wrong place at the wrong time: a case of cervical embryonal rhabdomyosarcoma in pregnancy. Gynecol Oncol Rep 2015; 12: 77-79
  • 16 Wiersema AM, Wobbes T, Pruszczynski M, van der Sluis RF. Malignant fibrous histiocytoma of the stomach during pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 1998; 80 (01) 71-73
  • 17 Otsuka K, Hamakawa H, Sumida T, Tanioka H. Treatment of mandibular malignant fibrous histiocytoma during pregnancy. J Oral Maxillofac Surg 2001; 59 (02) 220-224
  • 18 Su HW, Hsu CS, Lin YH, Hsu MI, Chiang HK, Chou SY. Malignant fibrous histiocytoma during pregnancy: a case report. Taiwan J Obstet Gynecol 2006; 45 (01) 86-88
  • 19 Buchanan TR, Kim SH, Pereira N. Infiltrating gluteal fibrosarcoma presenting as back pain in pregnancy. Int J Gynaecol Obstet 2013; 123 (02) 163-164
  • 20 Zhang W, Zheng X, Ni B. , et al. Myxoid fibrosarcoma of the left atrium and ventricle in pregnancy. Ann Thorac Surg 2014; 98 (05) 1818-1819
  • 21 Greenberg P, Collins JD, Voet RL, Jariwala L. Ewing's sarcoma metastatic to placenta. Placenta 1982; 3 (02) 191-196
  • 22 Sadat-Ali M, Ibrahim EM. Malignant bone tumours in pregnancy (a report of two cases and review of literature). Indian J Cancer 1989; 26 (03) 151-155
  • 23 Kathiresan AS, Johnson JN, Hood BJ, Montoya SP, Vanni S, Gonzalez-Quintero VH. Giant cell bone tumor of the thoracic spine presenting in late pregnancy. Obstet Gynecol 2011; 118 (2, Pt 2): 428-431
  • 24 Ortiz M, Giraldez LA, Riera-March A. Synovial sarcoma of the hypopharynx in pregnancy. Bol Asoc Med P R 2012; 104 (03) 55-56
  • 25 Nebhnani D, Fernandes G, Menon S, Naik L. Primary renal synovial sarcoma presenting in the first trimester of pregnancy. J Obstet Gynaecol India 2014; 64 (Suppl (Suppl. 01) 22-23
  • 26 Adameşteanu MO, Scurtu R, Lascăr I, Vâlcu M, Popescu ŞA, Sebe IT. Biphasic synovial sarcoma in a 19-year-old pregnant woman: a case report. Rom J Morphol Embryol 2015; 56 (01) 289-294
  • 27 Pathrose G, John NT, Hariharan P. Renal synovial sarcoma in a young pregnant lady: a case report and clinico-pathological profile. J Clin Diagn Res 2017; 11 (07) PD13 –PD14
  • 28 Molho RB, Kollender Y, Issakov J. , et al. The complexity of management of pregnancy-associated malignant soft tissue and bone tumors. Gynecol Obstet Invest 2008; 65 (02) 89-95
  • 29 Azim Jr HA, Peccatori FA. Managing cancer during pregnancy: what evidence do we have?. Pol Arch Med Wewn 2011; 121 (1, 2): 29-34
  • 30 Garofalo S, Degennaro VA, Salvi S. , et al. Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy?. Eur J Cancer Care (Engl) 2017 26. (06):
  • 31 Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Aozasa K. Angiosarcoma in Japan. A review of 99 cases. Cancer 1995; 75 (04) 989-996
  • 32 Pring ME, Weber KL, Unni KK, Sim FH. Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am 2001; 83-A (11) 1630-1642
  • 33 Leonard J, Gökden M, Kyriakos M, Derdeyn CP, Rich KM. Malignant giant-cell tumor of the parietal bone: case report and review of the literature. Neurosurgery 2001; 48 (02) 424-429
  • 34 Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer 1970; 25 (02) 380-388
  • 35 Dotters-Katz S, McNeil M, Limmer J, Kuller J. Cancer and pregnancy: the clinician's perspective. Obstet Gynecol Surv 2014; 69 (05) 277-286
  • 36 Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V. Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can 2013; 35 (03) 263-278
  • 37 Falkenberry SS. Cancer in pregnancy. Surg Oncol Clin N Am 1998; 7 (02) 375-397
  • 38 Al Khawaja D, Vescovi C, Dower A, Thiruvilangam V, Mahasneh T. Extra-skeletal Ewing sarcoma of the lumbosacral region in an adult pregnant patient: a case report. J Spine Surg 2017; 3 (01) 102-107
  • 39 Hockertz T, Velickovic M. Successful spontaneous pregnancy after treatment for Ewing sarcoma including sacrectomy. Case Rep Obstet Gynecol 2018; 2018: 2484036
  • 40 Gerstenfeld TS, Chang DT, Pliego AR, Wing DA. Nonobstetrical abdominal surgery during pregnancy in Women's Hospital. J Matern Fetal Med 2000; 9 (03) 170-172
  • 41 Merimsky O, Le Cesne A. Soft tissue and bone sarcomas in association with pregnancy. Acta Oncol 1998; 37 (7, 8): 721-727
  • 42 Merimsky O, Inbar M, Issakov J. , et al. Gestation-related malignant musculoskeletal tumors. Isr Med Assoc J 2003; 5 (04) 264-267
  • 43 Merimsky O, Le Chevalier T, Missenard G. , et al. Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the third trimester. Ann Oncol 1999; 10 (03) 345-350
  • 44 Zagouri F, Dimitrakakis C, Marinopoulos S, Tsigginou A, Dimopoulos MA. Cancer in pregnancy: disentangling treatment modalities. ESMO Open 2016; 1 (03) e000016
  • 45 ACOG Committee on Obstetric Practice. ACOG committee opinion no. 474: nonobstetric surgery during pregnancy. Obstet Gynecol 2011; 117 (2, Pt 1): 420-421